Home Page Overall Ranking ROE Ranking P/E Ranking Dividend Yield Capitalization Our eBook Our Book Contact










Isin CH0012032048
Ticker ROG.SW
Company ROCHE
Currency CHF
Price
Aware Investor Index (AII) 23.0216
Recommendation STRONG BUY
P/E 27.27
ROE 30.96 %
Capitalization 264,679,949,380 $
Dividend Yield 2.92 %
P/S 4.51
AII Position 81
P/E Position 385
ROE Position 91
Capitalization Position 31
Dividend Yield Position 241
Sales 56,846,000,000 CHF
10-Year Average Earnings 9,400,200,000 CHF
Shares Outstanding 860,000,000
Equity 30,366,000,000 CHF
Dividend per Share 8.7 CHF
Industry Pharmaceutical
Country Switzerland
ROCHE Investor Relations Web Site http://www.roche.com/investors.htm







Sales:

YEAR MONTH AMOUNT
2018 12 56,846,000,000.00 CHF
2017 12 53,299,000,000.00 CHF
2016 12 50,576,000,000.00 CHF
2015 12 48,145,000,000.00 CHF
2014 12 47,462,000,000.00 CHF
2013 12 46,780,000,000.00 CHF

Earnings:

YEAR MONTH AMOUNT
2018 12 10,865,000,000.00 CHF
2017 12 8,825,000,000.00 CHF
2016 12 9,733,000,000.00 CHF
2015 12 8,863,000,000.00 CHF
2014 12 9,332,000,000.00 CHF
2013 12 11,164,000,000.00 CHF
2012 12 9,427,000,000.00 CHF
2011 12 9,343,000,000.00 CHF
2010 12 8,666,000,000.00 CHF
2009 12 7,784,000,000.00 CHF

Equity:

YEAR MONTH AMOUNT
2018 12 30,366,000,000.00 CHF
2017 12 29,007,000,000.00 CHF
2016 12 26,402,000,000.00 CHF
2015 12 23,300,000,000.00 CHF
2014 12 21,558,000,000.00 CHF
2013 12 21,241,000,000.00 CHF
2012 12 16,728,000,000.00 CHF
2011 12 14,482,000,000.00 CHF

Shares Outstanding:

YEAR MONTH AMOUNT
2018 12 860,000,000
2017 12 860,000,000
2016 12 860,000,000
2015 12 862,000,000
2014 12 863,000,000
2013 12 863,000,000
2012 12 848,000,000
2011 12 849,000,000

 












Bloomberg News for ROCHE:



Google News for ROCHE:



Back